🔎 Trials Near Me

Dachaigh › Galaran Autoimmune › North Carolina › Durham

Sgrùdaidhean clionaigeach Galaran Autoimmune ann an Durham, NC

Tha 15 sgrùdaidhean airson Galaran Autoimmune a’ lorg phàirtichean aig làraichean ann agus timcheall air Durham (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

Environmental Risk Factors for the Anti-synthetase Syndrome

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
  • NIEHS Clinical Research Unit (CRU), Research Triangle Park · 7 mìle air falbh
Aoisean 2 gu 100 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT01276470

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

A’ fastadhÌre 3
  • Duke University Hospital, Durham
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT06722235

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

A’ fastadhÌre 2/3
  • Duke University Medical Center - Accepting Young Adults and Juvenile Patients, Durham
  • University of North Carolina at Chapel Hill - Accepting Adult Patients, Chapel Hill · 10 mìle air falbh
Aoisean 6 gu 75 · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT06154252

Daratumumab in Primary Antiphospholipid Syndrome

A’ fastadhÌre 1/2
  • Duke University, Durham
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT05671757

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

A’ fastadhÌre 1
  • Duke University Medical Center, Durham
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 10 Sult 2026 · NCT07085104

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

A’ fastadhÌre 3
  • Duke University Hospital, Durham
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT06948318

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

A’ fastadhÌre 3
  • GSK Investigational Site, Durham
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT06572384

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

A’ fastadhÌre 1/2
  • UNC Chapel Hill, Chapel Hill · 10 mìle air falbh
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 26 Lùna 2026 · NCT06121297

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

A’ fastadhÌre 2/3
  • Duke University, Durham
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 17 Lùna 2026 · NCT06328777

A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

A’ fastadhÌre 3
  • Duke University Medical Center, Durham
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT06056297

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

A’ fastadhÌre 3
  • Site Number - 1013, Durham
  • Site Number - 1020, Chapel Hill · 10 mìle air falbh
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 30 Iuch 2026 · NCT07039916

A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

A’ fastadhÌre 1
  • Duke University, Durham
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Iuch 2026 · NCT07115745

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

A’ fastadhSgrùdadh amharc
  • Duke University Medical Center, Durham
  • University of North Carolina at Chapel Hill, Chapel Hill · 10 mìle air falbh
Gach aois · Gach gnè · Air ùrachadh 6 Iuch 2026 · NCT01351545

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

A’ fastadhÌre 1
  • Duke University Health System, Durham
Aoisean 12 gu 70 · Gach gnè · Air ùrachadh 22 Cèit 2026 · NCT06308978

Maternal Autoimmune Disease Research Alliance (MADRA) Registry

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
  • Duke University, Durham
Gach aois · Banairean · Air ùrachadh 8 Faoi 2026 · NCT03276923

Sgrùdaidhean Galaran Autoimmune ann am bailtean eile

Sgrùdaidhean eile ann an Durham

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.